相似文献
1
Circulating complement levels and C3 glomerulopathy.
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1829-31. doi: 10.2215/CJN.09620914. Epub 2014 Oct 23.
2
Defining the complement biomarker profile of C3 glomerulopathy.
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1876-82. doi: 10.2215/CJN.01820214. Epub 2014 Oct 23.
3
A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
Clin Immunol Immunopathol. 1989 Mar;50(3):333-47. doi: 10.1016/0090-1229(89)90141-4.
4
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
J Am Soc Nephrol. 2018 Jan;29(1):283-294. doi: 10.1681/ASN.2017030258. Epub 2017 Oct 13.
5
C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.
Clin J Am Soc Nephrol. 2021 Nov;16(11):1639-1651. doi: 10.2215/CJN.00320121. Epub 2021 Sep 22.
6
Anti-Factor B Antibodies and Acute Postinfectious GN in Children.
J Am Soc Nephrol. 2020 Apr;31(4):829-840. doi: 10.1681/ASN.2019080851. Epub 2020 Feb 7.
7
Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritic factor and persistently low complement C3 and C5.
Pediatr Nephrol. 1992 May;6(3):239-43. doi: 10.1007/BF00878356.
8
Hypocomplementemia in a newborn infant caused by placental transfer of C3 nephritic factor.
J Pediatr. 1978 Jan;92(1):88-90. doi: 10.1016/s0022-3476(78)80083-3.
9
Does nephritic factor relate to the disease activity in hypocomplementemic membranoproliferative glomerulonephritis?
Nephron. 1992;62(1):116. doi: 10.1159/000187012.
10
High prevalence of hepatitis C virus antibodies in older patients with membranoproliferative glomerulonephritis.
Nephron. 1999;82(4):366-7. doi: 10.1159/000045459.
引用本文的文献
1
Kidney transplant in patients with C3 glomerulopathy.
Clin Kidney J. 2025 Apr 30;18(5):sfaf134. doi: 10.1093/ckj/sfaf134. eCollection 2025 May.
2
C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation.
Front Nephrol. 2024 Oct 29;4:1460146. doi: 10.3389/fneph.2024.1460146. eCollection 2024.
3
X-linked C1GALT1C1 mutation causes atypical hemolytic uremic syndrome.
Eur J Hum Genet. 2023 Oct;31(10):1101-1107. doi: 10.1038/s41431-022-01278-5. Epub 2023 Jan 4.
4
A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease.
Int J Mol Sci. 2020 Jan 14;21(2):525. doi: 10.3390/ijms21020525.
5
C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction.
Case Rep Nephrol Dial. 2018 Feb 8;8(1):25-34. doi: 10.1159/000486848. eCollection 2018 Jan-Apr.
本文引用的文献
1
Defining the complement biomarker profile of C3 glomerulopathy.
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1876-82. doi: 10.2215/CJN.01820214. Epub 2014 Oct 23.
2
Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
Semin Thromb Hemost. 2014 Jun;40(4):416-21. doi: 10.1055/s-0034-1375701. Epub 2014 May 5.
3
C3 glomerulopathy: consensus report.
Kidney Int. 2013 Dec;84(6):1079-89. doi: 10.1038/ki.2013.377. Epub 2013 Oct 30.
4
Overview of complement activation and regulation.
Semin Nephrol. 2013 Nov;33(6):479-92. doi: 10.1016/j.semnephrol.2013.08.001.
5
Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement.
Kidney Int. 2013 Feb;83(2):293-9. doi: 10.1038/ki.2012.384. Epub 2012 Dec 12.
6
Factor H autoantibodies in membranoproliferative glomerulonephritis.
Mol Immunol. 2012 Oct;52(3-4):200-6. doi: 10.1016/j.molimm.2012.05.009. Epub 2012 Jun 20.
7
C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
Kidney Int. 2012 Aug;82(4):465-73. doi: 10.1038/ki.2012.212.
8
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28.
9
Three kidneys, two diseases, one antibody?
Nephrol Dial Transplant. 2011 Nov;26(11):3811-3. doi: 10.1093/ndt/gfr436. Epub 2011 Aug 3.
10
Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.
Clin J Am Soc Nephrol. 2011 May;6(5):1009-17. doi: 10.2215/CJN.07110810. Epub 2011 Mar 17.
Zotero 插件